Life Science Fundraising & Investment
24 March 2026 - Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa)25-26 March 2026 - Main days, Lisbon Congress Centre, Lisbon, PortugalSpring Innovation Week 2026 Attendees
See below the companies joining the week.
| Company Name |
| 2EyesVision |
| 2EyesVision SL |
| 3D-PharmXchange |
| 3PBIOVIAN |
| 3T Biosciences |
| 3xP Global |
| 415 Capital |
| 4B Technologies |
| 819 Capital Partners |
| AbbVie |
| AbbVie Ventures AbbVie Germany |
| Ablexis, LLC |
| Achelous Partners |
| Adalyon |
| Adalyon |
| Adbio partners |
| Addex Therapeutics |
| Adocia |
| Advantary Capital Partners |
| Afendis Capital Management |
| Affilogic |
| AFYX Therapeutics A/S |
| AI Medical Technology |
| Ailux |
| Aixial Group |
| Aixial Group |
| Ajinomoto Co., Inc |
| Akasi Pharma |
| Akasi Pharma |
| Alector |
| Allarity Therapeutics Inc. |
| Almac Group |
| Alphabiome AI |
| Alphalytik Pharmaservice GmbH |
| ALTs Ventures |
| Alvotech |
| AM-Pharma |
| AMW GmbH |
| AnexAPep Inc. |
| Angios Flexco |
| Antabio SAS |
| Antabio SAS |
| Antabio SAS |
| Antabio SAS |
| Apollo Health Ventures |
| Apposite Capital |
| Araris Biotech AG |
| ArchiMed |
| Arcinova |
| Arctoris |
| Arctoris |
| Ardena |
| Ardena Holding NV |
| Arivin therapeutics |
| Arivin therapeutics |
| Arog Pharmaceuticals, Inc. |
| Arpeggio Bio |
| Arrowhead Pharmaceuticals |
| ARTIMMUNE SAS |
| ASABYS PARTNERS |
| Astellas |
| Astellas |
| AstraZeneca |
| Atuka Inc. |
| AurorA Science |
| Aurora Sterilisation |
| Avant Bio |
| Avant Bio |
| Avidicure B.V. |
| AXA IM Global Health Fund |
| Axa Investment Managers |
| Baio Labs |
| BattreVi AB |
| Baxter |
| Bayer |
| BD |
| Beiersdorf AG |
| Beiersdorf AG |
| Beijing Sungen Biomedical Technology Co., Ltd. |
| Beijing Youngen Biotechnology Co., Ltd. |
| Berlin Chemie AG - Menarini Group |
| Between Talks |
| Beyond Drug Development |
| BGV |
| Biaffin GmbH & CoKG |
| Biocant Park |
| BIOCODEX |
| BioConnection |
| BioConnection |
| BioConnection B.V. |
| Biocytogen Pharmaceuticals (Beijing) |
| Biocytogen Pharmaceuticals Beijing |
| Biocytogen Pharmaceuticals Beijing |
| BIODOL THERAPEUTICS |
| BioGeneration Ventures |
| BIOIO, Inc |
| BioKier, Inc. |
| BIOLIGHY |
| Biolojic Design |
| BioMed X AG |
| BiomedVC AG |
| BioNTech SE |
| Biorce |
| BioResearchAI.Co.,Ltd. |
| BioResearchAI.Co.,Ltd. |
| Biosion |
| Biovance Capital |
| Biovance Capital |
| BioVersys AG |
| Bioworkshops |
| BlackRock |
| Blue Matter |
| Bluepharma Industria |
| Blueprint Medicines |
| Blueskin |
| BNC Korea Co., Ltd. |
| Brainworks |
| Brenus Pharma |
| Brenus Pharma |
| Breslin AG |
| Brightlands Venture Partners |
| Brightlands Venture Partners B.V. |
| Brown Rudnick LLP |
| Brown Rudnick LLP |
| Buenavista Equity Partners |
| Bulgarian Angels Club UK |
| Business Region Göteborg |
| Business Region Göteborg |
| Byondis B.V. |
| Caelo VC |
| Caledonia Life Sciences |
| Cambridge Enterprise |
| Camida |
| Can Fite BioPharma (CANFY) |
| Canaccord Genuity |
| Candel Therapeutics |
| Capital Cell |
| Capital Cell |
| CARBOGEN AMCIS |
| Catalent |
| Catalyze BV |
| Catenion GmbH |
| CatSci |
| Causaly |
| C-Biomex |
| CeGaT GmbH |
| CellFiber Co., Ltd. |
| CellFiber Co., Ltd. |
| CellFiber Co., Ltd. |
| Celliaz |
| Cerbios-Pharma SA |
| Cereno Scientific |
| Ceryx Medical Ltd |
| CGE Partners |
| Chelatec |
| ChemCon GmbH |
| Chemspace |
| Chiesi Farmaceutici Spa |
| Chiesi Group |
| Choose Paris Region |
| CIC bioGUNE |
| CIF |
| CILcare |
| Cilcare |
| Circurna, Inc. |
| Claret Capital Partners |
| Clarma Capital |
| Clave Capital |
| Clinigen |
| CNS Pharmaceuticals |
| CNS Pharmaceuticals |
| Cobin Angels |
| COCOON BIOSCIENCES |
| Colab Accelbio |
| Conscious Capital Holdings Co. |
| Conscious Capital Holdings Co. |
| Contera Pharma |
| Contera Pharma A/S |
| Contera Pharma A/S |
| Convergence partner |
| Convergence Partners |
| Convergence Partners VC |
| Corundum |
| CR Ventures |
| CRB Health Tech SGEIC |
| CRITERIA BIO VENTURES |
| CTI Life Sciences Fund |
| CTS LTD |
| Cytocast Hungary Kft |
| Cytocast Hungary Kft |
| CYTOO |
| CZ Vaccines |
| Daiichi Sankyo Europe GmbH |
| Daiichi Sankyo Europe GmbH |
| Daiichi Sankyo Europe GmbH |
| Dawn Sea Therapeutics |
| Daye |
| Debiopharm Innovation Fund SA |
| Debiopharm International S.A. |
| Deepbridge Capital |
| DeepLook Medical |
| Department for Business and Trade |
| Desire Ventures Inc |
| DETHERA Therapeutics |
| DIVERCHIM CDMO |
| Dr. Ebeling & Assoc. GmbH |
| Dr. Falk Pharma GmbH |
| DTI DONATION & TRANSPLANTATION INSTITUTE |
| DyDo Pharma |
| EA Pharma Co., Ltd. |
| Earlybird Venture Capital |
| Edesa Biotech |
| EIFO (Sovereign Wealth Fund of Denm |
| Eir Ventures |
| Eisai |
| Elekta |
| Eli Lilly |
| Elpen Pharmaceutical Co. Inc |
| Enhanced Genomics |
| EQT Life Sciences |
| Er-Kim Pharmaceuticals |
| Er-Kim Pharmaceuticals |
| Esperante Ventures |
| Eupraxia Pharmaceuticals |
| EUROFINS OPTIMED |
| Evidence Ventures |
| Evotec |
| Exogenus Therapeutics |
| Experimental Pharmacology & Oncology Berlin-Buch |
| FaaS Capital |
| Faber VC |
| Family Office |
| Farmol Health Care Srl |
| FCR Therapeutics |
| FGI Capital |
| FiLeClo Sp. z o.o. |
| Flagship Pioneering |
| Flagship Pioneering |
| Flerie |
| Flobas Ventures |
| Flow |
| Forbion |
| Forbion |
| Forta Bio |
| Forta Bio |
| Fraunhofer ITEM |
| Fred Hutchinson Cancer Center |
| FUNDAÇAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE |
| Future Planet Capital |
| FyoniBio GmbH |
| Gad Medical |
| Galileo Research srl |
| Galux Inc. |
| Gazelle Tech |
| GED Ventures Portugal |
| GeneCell Studio |
| GeneScience Pharmaceuticals Co.,Ltd. |
| Genesupport |
| GeneT, Universidade de Coimbra |
| GeneT, Universidade de Coimbra |
| Genevant Sciences GmbH |
| Genmab |
| Genprex, Inc. |
| GenScend Biologics |
| George Mason University |
| Gesynta Pharma |
| Ghent University |
| Gilde Healthcare |
| Gilde Healthcare |
| GlobalData |
| GlobalData HealthCare |
| GlycoNex |
| GlycoTherapeutics |
| Gnosis SpA |
| Go Capital |
| Golf And Studio |
| Golgi Neurosciences |
| Granzer Regulatory Consulting & Services GmbH |
| Great Bay Bio Limited |
| Greater Geneva Bern area |
| Grünenthal GmbH |
| GSK |
| GSK |
| H Tree Capital |
| Hamamatsu Pharma Research, Inc. |
| Hangzhou Huasai Biomedicine Co., Ltd |
| HayFin |
| HBM Partners |
| HCVC |
| Heal Capital |
| Health Incubator Helsinki |
| Health Incubator Helsinki |
| Health Wildcatters |
| HealthCare Royalty |
| Heitner Biopharm Consultation |
| Hemispherian AS |
| Hemofarm AD |
| HERAN Partners BV |
| Heron Therapeutics, Inc. |
| Hexarad |
| Hitachi Ventures |
| HLB Life Science R&D |
| Hokkaido University |
| Hologic |
| Hovione SA |
| Hox Therapeutics Ltd |
| HTGF |
| HTGF | High-Tech Gründerfonds |
| Huadong Medicine Co., Ltd |
| Huma Therapeutics Ltd |
| HungaroTrial |
| Hyloris Developments |
| HYUNDAI PHARM |
| i&i Biotech Fund I SCSp |
| i&i Prague, s.r.o. |
| iBionext |
| Icosagen Cell Factory OÜ |
| Idevax |
| Idevax |
| IDR |
| Ie Sung International |
| IGA Technology Services Srl |
| IGES Institut |
| Ikarovec Limited |
| Immunethep |
| ImmunoDesigners Co., Ltd. |
| ImmuONE |
| INBISTRA |
| Indaco Venture Partners |
| Industrifonden |
| Industrifonden |
| Informa |
| Informa – EBD Group |
| Informa – partneringONE |
| InnoGI Technologies |
| InnoMedica Schweiz AG |
| InnovationQuarter |
| Innovestor |
| Innovo Therapeutics Inc. |
| INOGROUP |
| INOVIO Pharmaceuticals, Inc. |
| INOVOTION |
| Insilico Medicine |
| Insilico Medicine |
| Insilico Medicine |
| Institut Imagine |
| International Family Offices Alliance |
| Interventional Systems |
| Invest in Skane |
| Invest in skåne |
| IOCB Tech |
| Ipsen |
| iQure Pharma Inc |
| IQVIA |
| IRBLleida |
| istituto gentili srl |
| Itochu Europe PLC |
| ITR Laboratories |
| ITR Laboratories Canada Inc |
| Jazz Pharmaceuticals |
| JD Bioscience |
| Johnson & Johnson Innovation |
| Julius Clinical |
| Justin Stindt Consulting GmbH |
| JustPartnering |
| Kadans Science Partner Germany GmbH |
| Kairos Bioconsulting LLC |
| KAKEN PHARMACEUTICAL CO., LTD. |
| Kali Therapeutics |
| Kamada LTD |
| Kaneka Eurogentec S.A. |
| Karista |
| KCI Biotech (Suzhou) Inc. |
| Kerna Ventures |
| Kidron Capital |
| KINE SCIENCES, INC. |
| Kissei America, Inc. |
| KLIFO A/S |
| Klosterfrau Healthcare Group |
| KU Leuven |
| Kuhnil Pharm |
| Kurma Partners |
| Kurma Partners |
| KYBORA HOLDINGS INC. - SUCURSAL EM PT |
| Kyowa Kirin |
| Labatec Pharma SA |
| LabGenius Therapeutics |
| Laboratoire Aguettant |
| Lario Therapeutics Limited |
| Lead Discovery Center GmbH |
| Leads To Development |
| Leads To Development |
| LGCHEM |
| Life Science Buzz |
| Life Sciences Real Estate Limited |
| Lifespan Vision Ventures |
| LiGalli |
| LinXis BV |
| Locust Walk |
| London & Partners |
| LongRiver Investments |
| LongRiver Investments |
| Lonza |
| Loop Lab Bio GmbH |
| LSV Capital Partners |
| LSWorks |
| LSX |
| LSX |
| Luye Pharma Switzerland AG |
| M Ventures |
| Magma Science |
| Maruho Co.,Ltd. |
| Matisse Pharmaceuticals B.V. |
| Matisse Pharmaceuticals BV |
| Max Planck Institute of Biophysics |
| Maxion Therapeutics |
| MCE CARREL |
| MDV |
| medac pharma srl |
| Meddenovo Drug Design SAS |
| Meddenovo Drug Design SAS |
| Medevice |
| Medevice |
| MEDIAIPLUS |
| Medicines Discovery Catapult Limited |
| Medincell |
| MEDKAP Investor Association |
| MedPharm |
| Menarini Group |
| Merck KGaA |
| Merck Serono Ltd. |
| Mercurna |
| Mercurna BV |
| Merieux Equity Partners |
| Mérieux Equity Partners |
| MIMARK Diagnostics, S.L. |
| Modi Ventures |
| Momentum Biotech |
| Monograph Capital Partners |
| Montreal International |
| MSD Animal Health |
| MTIP AG |
| myotwin |
| myotwin |
| Nanexa AB |
| NanoCell Therapeutics |
| NanoCell Therapeutics B.V. |
| NanoVation Therapeutics |
| NatIgGs GmbH |
| Navinci Diagnostics AB |
| NBCD |
| Nerai Bioscience |
| Nerai Bioscience |
| Neurenati Therapeutics Inc |
| NeuroCores, Inc. |
| NEUROSCIENCE INNOVATIVE TECHNOLOGIES SL |
| Neurospector - VU University |
| NEUWERK Partnerschaft von Rechtsanwält:innen mbB |
| NewBiologix SA |
| Nina Capital |
| Nodenza Venture Partners |
| NodThera |
| Nordic Infucare |
| Novartis |
| Novartis Pharma AG |
| Novo Holdings |
| Novo Holdings A/S |
| Novo Nordisk |
| NovoNordisk |
| NV NOM |
| Nykode Therapeutics |
| OBI Pharma, Inc. |
| Ochre Bio |
| Octave Bio |
| OLAVIDE NEURON STX |
| oloBion |
| OncoBone Therapeutics Ltd |
| OncoInsight |
| One Nucleus |
| Onechain Immunotherapeutics |
| ONIRIA THERAPEUTICS, S.L. |
| ONIRIA THERAPEUTICS, S.L. |
| Only Orphans Cote |
| Optimum Strategic Communications |
| Optum Ventures |
| Oranda Therapeutics Limited |
| Orchard Therapeutics |
| ORGANOPlus Co., Ltd. |
| Orion Biotechnology |
| Orion Pharma |
| Orizuru Therapeutics,Inc. |
| Ottimo Pharma |
| Oxeltis |
| Oxford Biomedica |
| Oxford Science Enterprises |
| p53 Invest |
| Pace Ventures |
| Palatin Technologies, Inc. |
| palleos healthcare GmbH |
| Panacea Diagnostics |
| Panakes Partners |
| Paris-Saclay development authority |
| Partner International Inc. |
| Pathos AI |
| P-BIO |
| Pensatech Pharma GmbH |
| Peppermint VenturePartners |
| Pfizer Inc. |
| Pharma Bavaria Internacional (PBI) Portugal Unip. Lda |
| Pharma Capital Partners |
| Pharmainformatic |
| PharmaKrysto Ltd |
| pharmalink |
| PharmaMar |
| Pharmaron UK Ltd. |
| Pharmatest Services |
| Pharos iBio |
| Phinomics |
| Phinomics |
| Phinomics, Inc. and Phinomics, GmbH |
| Phosphoenix |
| PIERRE FABRE |
| Pioneer Group |
| Plasseraud IP |
| Playground Global |
| Plug and Play Germany |
| Pneubera AB |
| PocDoc |
| Porton Advanced Solutions Ltd |
| Precision BioTools |
| Priavoid GmbH |
| PRISM BioLab Co., Ltd. |
| Private |
| PRO.MED.CS Praha a.s. |
| ProBioGen AG |
| Prokarium |
| Protagonist Therapeutics |
| Protalix Biotherapeutics |
| PROTEROS biostructures GmbH |
| Pullan Consulting |
| Qbic Fund |
| Qiming Venture Partners |
| Quant Health |
| QUANTRO Therapeutics |
| Qurient Co., Ltd. |
| Rab Diagnostics AS |
| Rab Diagnostics AS |
| Radboud universitair medisch centrum |
| Rafa |
| Rallybio |
| Rallybio |
| Raven biosciences |
| RedHill Biopharma Ltd. |
| Rentschler Biopharma SE |
| Rentschler Biopharma SE |
| Resalis Therapeutics |
| Resalis Therapeutics |
| Resitu Medical AB |
| Rezon Bio |
| RIANA Therapeutics GmbH |
| Ribbon Biolabs |
| Ribbon Biolabs GmbH |
| Rigel Pharmaceuticals Inc |
| Roche |
| Rocket Bio Capital |
| ROIS |
| Ryvu Therapeutics |
| S3 Connected Health |
| SaniMed Science Group |
| Sartorius Polyplus |
| Scinai Immunotherapeutics Ltd. |
| Secarna Pharmaceuticals |
| Segulah Medical Acceleration |
| Segulah medicalCON |
| Selvita S.A. |
| Sequentiq BV |
| Serenatis Bio |
| Serendo Therapeutics AB |
| Serpentine Ventures |
| Serpin Pharma |
| Servier |
| Servier |
| Servier |
| Servier |
| SGS |
| Shanghai Jeyou (Jemincare) Pharmaceutical Co, Ltd |
| Shanghai Medicilon UK/EU Office |
| Ship2B Ventures |
| Ship2b Ventures |
| Siemens Healthineers |
| Sightera Biosciences |
| Sightera Biosciences |
| Sightera Biosciences |
| Skyepharma |
| Skyhawk Therapeutics |
| Skyhawk Therapeutics |
| Slingshot Therapeutics |
| SmartCella |
| SmartCella |
| SMC Laboratories, Inc. |
| SNGLR Group |
| SOFINNOVA PARTNERS |
| Sol-Gel |
| Solventum |
| SOTIO Biotech a.s. |
| SOTIO Biotech a.s. |
| Sound Bioventures |
| Spago Nanomedical AB |
| Sparrow Pharmaceuticals, Inc. |
| Spectralys Biotech SRL |
| Spectralys Biotech SRL |
| SphingoTec GmbH |
| SpringWorks Therapeutics |
| SpringWorks Therapeutics |
| Sprint Bioscience |
| Spyre Therapeutics |
| Staatz Consulting Business Development, Market Access and HTA |
| STAB VIDA, Lda |
| STADA Arzneimittel AG |
| Starpharma |
| StoneCalibre |
| Strike Pharma |
| SunRock Biopharma S.L. |
| Sunstone Life Science Ventures |
| Sunstone Life Science Ventures |
| SWC Partners |
| Swiss Biotech Association |
| Sygnature Discovery |
| Synact Pharma |
| Syncona |
| Syncona Investment Management Ltd |
| SyVento BioTech |
| Taiho Oncology |
| Takis |
| Taldeki Biosolutions |
| Talus Bio |
| Taros Chemicals GmbH & Co. KG |
| TCD Capital |
| Tcelltech |
| TCP Health Ventures |
| TECH MANAGE CORP. |
| Teikoku Pharma USA, Inc. |
| ten23 health AG |
| Tencent |
| Terafront Farmatech SL |
| Tetra Pharm Technologies ApS |
| Tetraneuron |
| Tetraneuron |
| The Fulford Group |
| The IOT Magazine |
| tiakis Biotech AG |
| Tigermed |
| TMC Pharma Services Ltd |
| TNO |
| Topadur Pharma |
| Topadur Pharma AG |
| Topadur Pharma AG |
| Topadur Pharma AG |
| Topia Pharma Intelligence Limited |
| Torrey Pines Investment |
| TransCure bioServices |
| Transpharmation Ltd. |
| TrueMed Therapeutics |
| Truffle Capital |
| Tulane University Innovation Institute |
| Umlaut.bio GmbH |
| Umlaut.bio GmbH |
| UNEEG medical |
| UniQuest Pty Ltd |
| United Therapeutics Corporation |
| University Medical Center Utrecht |
| University of Edinburgh |
| University of Geneva |
| University of Ghent |
| University of Melbourne |
| Untethered Ventures |
| Vactech Oy |
| Valvian |
| VECT-HORUS |
| Veritus Research |
| Vesalius Biocapital IV PArtners sar |
| Vetter Pharma International |
| Vetter Pharma International GmbH |
| Vianautis Bio Ltd. |
| Viatris |
| Victor Chang Cardiac Research Institute |
| ViSync Technologies |
| Vivtex Corporation |
| VoxCell BioInnovation |
| VRG Therapeutics LTD |
| Wandercraft |
| Wave Immune |
| Weixinkang Pharmaceutical Co., LTD |
| Wellington Partners |
| WhanIn Pharm |
| Will Pharma SA |
| WLAN Holding |
| WuXi Biologics USA LLC |
| XGEN Venture |
| Xplico ApS |
| Xsensio |
| YAFO Capital (Shanghai) |
| Ymmunobio AG |
| Ysios capital |
| YUMAB GmbH |
| Zambon Biotech SA |
| Zcube, Zambon Research Venture |
| Zetobit Bioinformatics |
| Zinc VC |